Embecta Q1 2026 supplier risk profile: 61 shipments from 2 suppliers across Ireland and China.
Embecta imported 61 shipments in Q1 2026 from two suppliers across two countries. Ireland accounts for 92% of shipments via Embecta Penel, which supplied 56 shipments of medical devices (HS Chapter 90). The remaining 8% comes from Embecta Medical Devices Suzhou in China with 5 shipments.
Trigram screen against OFAC SDN, BIS Entity List, UFLPA Entity List, SAM Exclusions, EU FSF, UK HMT, UN SC, and 25+ allied jurisdictions.
Distance-screened against all 380 facilities in the ASPI Xinjiang Data Project. Proximity score: 100 / 100.
Embecta has no sanctions watchlist matches and no suppliers with identified UFLSA forced-labor exposure. The company's import profile presents no flagged compliance concerns in these areas.
2 distinct tier-1 suppliers in Q1 2026
| EMBECTA PENEL | Ireland | 56 |
| EMBECTA MEDICAL DEVICES SUZHOU | China | 5 |
Share of Q1 2026 inbound shipments by source country
3 tier-2 + 0 tier-3 nodes mapped - sign up to see them.
Free Tarifflo account unlocks the complete tier 1 / 2 / 3 supplier graph, daily refresh, alerts, and sanctions + UFLPA monitoring on every shipment.